Yasuhiro Ishihara Selected Research

Cytochromes

1/2021

Contribution of DHA diols (19,20-DHDP) produced by cytochrome P450s and soluble epoxide hydrolase to the beneficial effects of DHA supplementation in the brains of rotenone-induced rat models of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiro Ishihara Research Topics

Disease

8	Inflammation (Inflammations) 01/2023 - 01/2013
6	Status Epilepticus (Complex Partial Status Epilepticus) 07/2022 - 05/2015
5	Neuroinflammatory Diseases 01/2023 - 01/2015
5	Neuroblastoma 12/2022 - 12/2011
5	Seizures (Absence Seizure) 07/2022 - 05/2015
5	Neoplasms (Cancer) 01/2021 - 01/2013
3	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2021
3	Edema (Dropsy) 01/2021 - 05/2015
3	Brain Edema (Cerebral Edema) 01/2018 - 05/2015
3	Infarction (Infarctions) 01/2018 - 06/2009
3	Myocardial Infarction 09/2015 - 01/2010
3	Insulin Resistance 05/2015 - 09/2010
3	Ischemia 11/2012 - 01/2010
3	Reperfusion Injury 11/2012 - 06/2009
2	Febrile Seizures (Febrile Seizure) 01/2023 - 01/2021
2	Ischemic Stroke 01/2023 - 01/2021
2	Asthma (Bronchial Asthma) 01/2022 - 10/2018
2	Epilepsy (Aura) 01/2021 - 05/2015
2	Heart Failure 10/2018 - 03/2012
2	Obesity 07/2015 - 07/2014
1	Movement Disorders (Movement Disorder) 01/2023
1	Autism Spectrum Disorder 07/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2022
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Placenta Previa 06/2019
1	Placenta Accreta 06/2019
1	Lymphoma (Lymphomas) 04/2019
1	Gliosis 01/2019
1	Premature Birth (Birth, Premature) 10/2018
1	Hypersensitivity (Allergy) 06/2018

Drug/Important Bio-Agent (IBA)

6	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2023 - 01/2019
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 06/2009
5	Pilocarpine (Ocusert)FDA LinkGeneric 07/2022 - 05/2015
5	Levetiracetam (Keppra)FDA LinkGeneric 07/2022 - 05/2015
4	Docosahexaenoic AcidsIBA 01/2023 - 01/2017
4	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2012 - 06/2009
4	Sulfaphenazole FDA Link 01/2012 - 06/2009
3	CytokinesIBA 07/2022 - 01/2018
3	RotenoneIBA 11/2021 - 12/2011
3	Diazepam (Valium)FDA LinkGeneric 01/2019 - 05/2015
2	Pentylenetetrazole (Metrazol)IBA 01/2023 - 01/2017
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2023 - 01/2019
2	Anticonvulsants (Antiepileptic Drugs)IBA 07/2022 - 01/2019
2	Valproic Acid (Depakote)FDA LinkGeneric 07/2022 - 01/2019
2	LipopolysaccharidesIBA 07/2022 - 01/2013
2	Interleukin-33IBA 01/2022 - 01/2019
2	Estrogens (Estrogen)FDA Link 01/2021 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2012
2	DioxinsIBA 01/2021 - 04/2019
2	SeleniumIBA 06/2019 - 10/2018
2	CadmiumIBA 06/2019 - 10/2018
2	MercuryIBA 06/2019 - 10/2018
2	ManganeseIBA 06/2019 - 10/2018
2	AdipokinesIBA 07/2014 - 09/2010
2	olmesartanIBA 03/2012 - 07/2009
2	Glucose (Dextrose)FDA LinkGeneric 12/2011 - 07/2009
2	Lipid PeroxidesIBA 01/2010 - 06/2009
1	superoxide dismutase 2IBA 01/2023
1	Cell ExtractsIBA 01/2023
1	3-azido-2,7-naphthalene disulfonateIBA 01/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Pattern Recognition ReceptorsIBA 01/2023
1	naphthionic acidIBA 01/2023
1	AcidsIBA 01/2023
1	AerosolsIBA 01/2023
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2022
1	Air Pollutants (Pollutants, Air)IBA 01/2022
1	EndotoxinsIBA 01/2022
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2021
1	Interleukin-22 (IL-22)IBA 01/2021
1	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideIBA 01/2021
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2021
1	CarcinogensIBA 01/2021
1	CytochromesIBA 01/2021
1	Epoxide HydrolasesIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Caspase 3 (Caspase-3)IBA 10/2020
1	MetalsIBA 06/2019
1	Polychlorinated Dibenzodioxins (TCDD)IBA 04/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2019
1	Glial Fibrillary Acidic ProteinIBA 01/2019
1	fluorocitrateIBA 01/2019
1	EnzymesIBA 01/2019
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2019
1	Particulate MatterIBA 01/2019
1	Heavy MetalsIBA 10/2018
1	trimellitic anhydrideIBA 06/2018
1	Immunoglobulin G (IgG)IBA 06/2018
1	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 06/2018
1	PlasticsIBA 06/2018
1	ChloridesIBA 01/2018
1	Minocycline (Cyclops)FDA LinkGeneric 01/2018
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 11/2016
1	Mitochondrial DNA (mtDNA)IBA 11/2016
1	Anticardiolipin AntibodiesIBA 11/2016
1	Antiphospholipid AntibodiesIBA 11/2016

Therapy/Procedure

2	Therapeutics 09/2015 - 01/2012
2	Ligation 11/2012 - 06/2009